For example, in RSL3 target-related studies, powerful inducers such as compound 26a have been developed, which can effectively inhibit GPX4 activity and induce ferroptosis, and have shown the potential to inhibit tumor growth in mouse models [27]. Here, GPX4 is linked to neoplasm.